Vaxcyte (PCVX) Prepaid Assets (2019 - 2026)

Vaxcyte (PCVX) has reported Prepaid Assets for 8 consecutive years, with $76.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets rose 70.21% year-over-year to $76.3 million; the TTM figure through Mar 2026 stood at $76.3 million (up 70.21% YoY), while the FY2025 annual figure was $66.4 million, up 3163.0% from the prior year.
• Prepaid Assets advanced to $76.3 million in Q1 2026 per PCVX's latest filing, from $66.4 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $76.3 million in Q1 2026 and bottomed at $1.3 million in Q3 2023.
• Historically, Prepaid Assets has averaged $27.5 million across 5 years, with a median of $23.3 million in 2023.
• Annual changes were most pronounced in 2023 — Prepaid Assets slumped 82.76% — and 2025, when it soared 3163.0%.
• Vaxcyte's Prepaid Assets stood at $5.3 million in 2022, then tumbled by 60.2% to $2.1 million in 2023, then dropped by 3.74% to $2.0 million in 2024, then jumped by 3163.0% to $66.4 million in 2025, then gained by 14.92% to $76.3 million in 2026.
• Business Quant data shows PCVX's Prepaid Assets at $76.3 million in Q1 2026, $66.4 million in Q4 2025, and $55.8 million in Q3 2025.